Loading…
Laparoscopic Versus Open Transperitoneal Nephrectomy for the Treatment of Giant Hydronephrosis
Objective: To assess the effectiveness of laparoscopic transperitoneal nephrectomy in the treatment of patients with giant hydronephrosis and to compare the results with open nephrectomy. Materials and Methods: We reviewed the data of 19 patients underwent laparoscopic (laparoscopic group, n=8) and...
Saved in:
Published in: | Journal of urological surgery 2020-12, Vol.7 (4), p.276-280 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective: To assess the effectiveness of laparoscopic transperitoneal nephrectomy in the treatment of patients with giant hydronephrosis and to
compare the results with open nephrectomy.
Materials and Methods: We reviewed the data of 19 patients underwent laparoscopic (laparoscopic group, n=8) and open (open group, n=11)
transperitoneal nephrectomy for giant hydronephrosis between January 2008 and 2018. Demographic characteristics, clinical, laboratory and
radiological findings of cases were examined. Perioperative and postoperative outcomes were reported. Mann-Whitney U and Fisher’s Exact tests
were used in the statistical analysis.
Results: The mean operation time was 112.5±19.1 (90-140) minutes and 107.2±19.1 (80-140) minutes, respectively, for the laparoscopic and open
groups (p=0.546). The mean hospitalization period was 3.5 (3-7) and 6 (5-8) days, respectively, for the laparoscopic and open approach (p=0.003).
No major complications during the perioperative period were observed in any of the patients. The mean follow-up periods were 36 (6-60) and 70
(39-80) months, respectively, for the laparoscopic and open groups (p=0.000).
Conclusion: Laparoscopic transperitoneal nephrectomy appears to be equally effective to the open approach with a shorter hospitalization period
for the treatment of giant hydronephrosis. It may be offered as a safe and acceptable model of treatment for patients presenting with giant
hydronephrosis. |
---|---|
ISSN: | 2148-9580 2148-9580 |
DOI: | 10.4274/jus.galenos.2020.3279 |